• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群和免疫标志物在结直肠腺瘤不同阶段的影响。

Influence of gut microbiota and immune markers in different stages of colorectal adenomas.

作者信息

Wang Xianmei, Chen Hang, Yang Meng, Huang Minshan, Zhang Dan, Li Mingke, Wang Hui, Zhou Qingqing, Lu Lihong, Li Yu, Yu Jiangkun, Ma Lanqing

机构信息

Yunnan Institute of Digestive Disease, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences, Yunnan University, Kunming, Yunnan, China.

出版信息

Front Microbiol. 2025 Apr 16;16:1556056. doi: 10.3389/fmicb.2025.1556056. eCollection 2025.

DOI:10.3389/fmicb.2025.1556056
PMID:40309115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040870/
Abstract

OBJECTIVE

Colorectal adenomas (CRA) are the primary precancerous lesions leading to colorectal cancer (CRC). Early detection and intervention of CRA can significantly reduce the incidence of CRC. We investigated the relationships between the gut microbiome and the expression levels of PD-L1, IL-6, and IFN-γ at different CRA stages.

METHODS

Participants were divided into normal, non-advanced adenoma (NAA), and advanced adenoma (AA) groups. PD-L1 expression in collected tissues was analyzed via immunohistochemistry (IHC) and Western blotting. Serum IL-6 and IFN-γ levels were measured using Enzyme-Linked Immunosorbent Assay (ELISA). 16S rRNA gene sequencing was used to examine gut microbiota changes, with correlation analysis to assess microbial influences on CRA progression.

RESULTS

The main differences in bacterial composition among the three groups were found within the Firmicutes and Bacteroidetes phyla. In the normal vs. NAA comparison, were more abundant in the normal group, while was enriched in the NAA group. For the normal vs. AA comparison, the normal group was enriched with , whereas was more abundant in the AA group. In the NAA vs. AA comparison, the NAA group exhibited higher levels of relative to the AA group. are positively correlated with PD-L1 protein levels progressively increase with CRA advancement. Additionally, were negatively associated with IFN-γ, while were positively associated with IL-6.

CONCLUSION

This study highlights the dynamic alterations in gut microbiota composition and their potential influence on the regulation of inflammatory cytokines and PD-L1 expression during CRA progression. The enrichment of protective taxa, such as and , in the normal group emphasizes their potential role in mitigating adenoma progression. Dietary modulation to promote the proliferation of these beneficial bacteria could serve as a promising strategy to improve colorectal health. Future research should further explore the specific relationships between dietary components, gut microbiota, and metabolic pathways, and assess the effects of dietary interventions on gut health.

摘要

目的

结直肠腺瘤(CRA)是导致结直肠癌(CRC)的主要癌前病变。CRA的早期检测和干预可显著降低CRC的发病率。我们研究了不同CRA阶段肠道微生物群与PD-L1、IL-6和IFN-γ表达水平之间的关系。

方法

将参与者分为正常组、非进展性腺瘤(NAA)组和进展性腺瘤(AA)组。通过免疫组织化学(IHC)和蛋白质免疫印迹法分析收集组织中PD-L1的表达。采用酶联免疫吸附测定(ELISA)测量血清IL-6和IFN-γ水平。使用16S rRNA基因测序检查肠道微生物群的变化,并进行相关性分析以评估微生物对CRA进展的影响。

结果

三组之间细菌组成的主要差异存在于厚壁菌门和拟杆菌门中。在正常组与NAA组的比较中,正常组中 更丰富,而 在NAA组中富集。在正常组与AA组的比较中,正常组中 富集,而 在AA组中更丰富。在NAA组与AA组的比较中,相对于AA组,NAA组 的水平更高。 与 呈正相关,PD-L1蛋白水平随着CRA进展而逐渐升高。此外, 与IFN-γ呈负相关,而 与IL-6呈正相关。

结论

本研究强调了肠道微生物群组成的动态变化及其在CRA进展过程中对炎性细胞因子调节和PD-L1表达的潜在影响。正常组中保护性分类群如 和 的富集强调了它们在减轻腺瘤进展中的潜在作用。通过饮食调节促进这些有益细菌的增殖可能是改善结直肠健康的一种有前景的策略。未来的研究应进一步探索饮食成分、肠道微生物群和代谢途径之间的具体关系,并评估饮食干预对肠道健康的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/e3dc3aaab034/fmicb-16-1556056-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/c8cf3bfba54a/fmicb-16-1556056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/60e2e708e7ec/fmicb-16-1556056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/ecc7c4f5a01d/fmicb-16-1556056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/c027eb11d4d9/fmicb-16-1556056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/95777700aa7f/fmicb-16-1556056-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/e3dc3aaab034/fmicb-16-1556056-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/c8cf3bfba54a/fmicb-16-1556056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/60e2e708e7ec/fmicb-16-1556056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/ecc7c4f5a01d/fmicb-16-1556056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/c027eb11d4d9/fmicb-16-1556056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/95777700aa7f/fmicb-16-1556056-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a32/12040870/e3dc3aaab034/fmicb-16-1556056-g006.jpg

相似文献

1
Influence of gut microbiota and immune markers in different stages of colorectal adenomas.肠道微生物群和免疫标志物在结直肠腺瘤不同阶段的影响。
Front Microbiol. 2025 Apr 16;16:1556056. doi: 10.3389/fmicb.2025.1556056. eCollection 2025.
2
Gut microbial and metabolomics profiles reveal the potential mechanism of fecal microbiota transplantation in modulating the progression of colitis-associated colorectal cancer in mice.肠道微生物和代谢组学特征揭示粪便微生物群移植调节结肠炎相关结直肠癌小鼠进展的潜在机制。
J Transl Med. 2024 Nov 15;22(1):1028. doi: 10.1186/s12967-024-05786-4.
3
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
4
Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysis.基于 16S rRNA 基因测序的结直肠腺瘤-癌序列中肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Oct;195:106889. doi: 10.1016/j.micpath.2024.106889. Epub 2024 Aug 26.
5
Association analysis of gut microbiota with LDL-C metabolism and microbial pathogenicity in colorectal cancer patients.结直肠癌患者 LDL-C 代谢与微生物致病性的肠道微生物关联分析。
Lipids Health Dis. 2024 Nov 8;23(1):367. doi: 10.1186/s12944-024-02333-4.
6
Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.使用 16SrRNA 测序研究微生物组与结直肠癌易感性的关系。
Biomed Res Int. 2020 Jan 30;2020:7828392. doi: 10.1155/2020/7828392. eCollection 2020.
7
Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.结直肠腺瘤-癌序列中肠道微生物群和血清代谢物特征:早期检测和干预的意义。
Clin Chim Acta. 2024 Jun 15;560:119732. doi: 10.1016/j.cca.2024.119732. Epub 2024 May 19.
8
Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer.粪便色氨酸代谢的改变与菌群移位相关,并可能与结直肠癌的发病机制有关。
World J Gastroenterol. 2020 Dec 7;26(45):7173-7190. doi: 10.3748/wjg.v26.i45.7173.
9
Correlation between gut microbiota composition, enteric infections and linear growth impairment: a case-control study in childhood stunting in Pidie, Aceh, Indonesia.肠道微生物群组成、肠道感染与线性生长障碍之间的相关性:印度尼西亚亚齐省比迪儿童发育迟缓的病例对照研究
Gut Pathog. 2023 Nov 9;15(1):54. doi: 10.1186/s13099-023-00581-w.
10
Different Characteristics in Gut Microbiome between Advanced Adenoma Patients and Colorectal Cancer Patients by Metagenomic Analysis.基于宏基因组分析的高级腺瘤患者和结直肠癌患者肠道微生物组的不同特征。
Microbiol Spectr. 2022 Dec 21;10(6):e0159322. doi: 10.1128/spectrum.01593-22. Epub 2022 Dec 1.

引用本文的文献

1
Effects of Long-Term Dietary Inclusion of Citrus Pomace on Growth Performance, Intestinal Morphology, Digestive Enzyme Activity, Antioxidant Status, and Colonic Microbiota in Tibetan Pigs.长期在日粮中添加柑橘渣对藏猪生长性能、肠道形态、消化酶活性、抗氧化状态及结肠微生物群的影响
Animals (Basel). 2025 Aug 11;15(16):2348. doi: 10.3390/ani15162348.

本文引用的文献

1
Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction.基于数据挖掘和算法预测探索参梅方防治大肠腺瘤复发的机制
Biol Proced Online. 2025 Feb 1;27(1):4. doi: 10.1186/s12575-025-00266-5.
2
Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer.膳食抗氧化剂、膳食纤维与肠道微生物组的相互作用:其在炎症和癌症中的潜在作用。
Int J Mol Sci. 2024 Jul 28;25(15):8250. doi: 10.3390/ijms25158250.
3
Solobacterium moorei promotes the progression of adenomatous polyps by causing inflammation and disrupting the intestinal barrier.
史密斯梭菌通过引起炎症和破坏肠道屏障促进腺瘤性息肉的进展。
J Transl Med. 2024 Feb 17;22(1):169. doi: 10.1186/s12967-024-04977-3.
4
The Possible Preventative Role of Lactate- and Butyrate-Producing Bacteria in Colorectal Carcinogenesis.产乳酸盐和丁酸盐细菌在结直肠癌发生中的可能预防作用。
Gut Liver. 2024 Jul 15;18(4):654-666. doi: 10.5009/gnl230385. Epub 2023 Nov 30.
5
Fecal Microbiota and Associated Volatile Organic Compounds Distinguishing No-Adenoma from High-Risk Colon Adenoma Adults.粪便微生物群及相关挥发性有机化合物对无腺瘤与高危结肠腺瘤成年人的鉴别作用
Metabolites. 2023 Jul 4;13(7):819. doi: 10.3390/metabo13070819.
6
PD-L1/PD-L1 signalling promotes colorectal cancer cell migration ability through RAS/MEK/ERK.PD-L1/PD-L1 信号通过 RAS/MEK/ERK 促进结直肠癌细胞迁移能力。
Clin Exp Pharmacol Physiol. 2022 Dec;49(12):1281-1293. doi: 10.1111/1440-1681.13717. Epub 2022 Sep 15.
7
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota.多功能三联体联盟:胆酸、牛磺酸和微生物群。
Cells. 2022 Jul 29;11(15):2337. doi: 10.3390/cells11152337.
8
Proteomic response of Turicibacter bilis MMM721 to chicken bile and its bile acids.双歧杆菌 MMM721 对鸡胆及其胆酸的蛋白质组反应。
BMC Res Notes. 2022 Jul 2;15(1):236. doi: 10.1186/s13104-022-06127-8.
9
Beneficial Effects of a Low-Glycemic Diet on Serum Metabolites and Gut Microbiota in Obese Women With and Enterotypes: A Randomized Clinical Trial.低升糖指数饮食对具有不同肠型的肥胖女性血清代谢物和肠道微生物群的有益影响:一项随机临床试验。
Front Nutr. 2022 May 2;9:861880. doi: 10.3389/fnut.2022.861880. eCollection 2022.
10
Immunosuppressive niche engineering at the onset of human colorectal cancer.免疫抑制微环境工程在人结直肠癌发病初期的应用。
Nat Commun. 2022 Apr 4;13(1):1798. doi: 10.1038/s41467-022-29027-8.